© The Board of Management and Trustees of the British Journal of Anaesthesia 2005. All rights reserved. For Permissions, please e-mail: journal.permissions@oupjournals.org
CORRESPONDENCE |
Recombinant factor VIIa for life-threatening post-partum haemorrhage
* E-mail: ajbut@stanford.edu
| The first 10% of the full text of this article appears below. |
EditorWe read with interest the article by Ahonen and colleagues.1 All patients in the case series sustained severe post-partum haemorrhage (PPH) and transfusion requirements were high. However, it is difficult to make assessments of the efficacy of recombinant factor VIIa (rFVIIa) from the data presented. As stated in the accompanying editorial,2 we need randomized controlled trials to determine whether rFVIIa is effective, but these studies are unlikely to be implemented in the setting of unanticipated PPH. However, the authors do have data available
Stanford, USA
* E-mail: jouni.ahonen@fimnet.fi
Helsinki, Finland